New therapy targets cause of adult-onset muscular dystrophy by Staff April 1, 2019 April 1, 2019 19 views 19The compound called Cugamycin works by recognizing toxic RNA repeats and destroying the garbled gene transcript.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post New polymer mixture creates ultra-sensitive heat sensor next post How the brain fights off fears that return to haunt us Related Posts Gonadal function in male mice disrupted by prenatal... June 14, 2024 Scientists solve decades long mystery of NLRC5 sensor... June 14, 2024 Vitamin B6: New compound delays degradation June 14, 2024 Strengthener for graphene June 14, 2024 The genetic ‘switches’ of bone growth June 14, 2024 Quantum entanglement measures Earth rotation June 14, 2024